BioTrove
Company

Last deal

Amount

Series C

Stage

22.04.2009

Date

7

all rounds

$41.5M

Total amount

General

About Company
Gene Analysis BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1997

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company offers various technology platforms, such as OpenArray for gene expression analysis, RapidFire for drug target screening, and a mass spectrometry hardware system for drug screening and in vitro ADME applications. Gene Analysis BioTrove also develops and manufactures laboratory instruments and consumables for genomic analysis, high-throughput screening, and molecular diagnostics. Their systems enable customers to rapidly perform multiple simultaneous PCR-based genomic analyses on single or multiple samples, accelerating research and development progress across multiple fields, from drug discovery to agricultural science.
Contacts

Social url